PRKG1 Antikörper (C-Term)

Produktnummer ABIN6258018

Produktdetails anti-PRKG1 Antikörper

Target: PRKG1 (Protein Kinase, CGMP-Dependent, Type I (PRKG1))

Bindungsspezifität: C-Term

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PRKG1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Spezifität: PRKG1 Antibody detects endogenous levels of total PRKG1.

Homologie: Pig,Bovine,Horse,Sheep,Rabbit,Dog,Chicken

Aufreinigung: The antiserum was purified by peptide affinity chromatography using SulfoLink^TM Coupling Resin (Thermo Fisher Scientific).

Immunogen: A synthesized peptide derived from human PRKG1, corresponding to a region within C-terminal amino acids.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:500-1:2000, ELISA(peptide) 1:20000-1:40000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Haltbarkeit: 12 months

Details zu PRKG1

Target: PRKG1 (Protein Kinase, CGMP-Dependent, Type I (PRKG1))

Andere Bezeichnung: PRKG1 (PRKG1 Produkte)

Synonyme: prkg1 antikoerper, zgc:63955 antikoerper, Pkgi antikoerper, cGk1 antikoerper, 1 antikoerper, PKG antikoerper, PRKG1B antikoerper, PRKGR1B antikoerper, cGK antikoerper, cGK 1 antikoerper, cGK1 antikoerper, cGKI antikoerper, cGKI-BETA antikoerper, cGKI-alpha antikoerper, CGKI antikoerper, cGKI-beta antikoerper, AW125416 antikoerper, Gm19690 antikoerper, Prkg1b antikoerper, Prkgr1b antikoerper, Prkg1beta antikoerper, protein kinase, cGMP-dependent, type Ia antikoerper, protein kinase, cGMP-dependent, type I antikoerper, protein kinase, cGMP-dependent, type 1 antikoerper, prkg1a antikoerper, PRKG1 antikoerper, prkg1 antikoerper, Prkg1 antikoerper

Hintergrund:

Description: Serine/threonine protein kinase that acts as key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smooth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates MRVI1/IRAG and inhibits IP3-induced Ca2+ release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca2+ levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation, decreasing contraction, controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling alters also gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle.

Gene: PRKG1

Molekulargewicht: 76 kDa

Gen-ID: 5592

UniProt: Q13976